Process for the preparation of bendamustine hydrochloride
AssigneeFresenius Kabi Oncology Limited
InventorsBhuwan Bhaskar Mishra, Nikunj Shambhubhai Kachhadia, Vinod Singh Tomar, Saswata Lahiri
Life of this patent
Estimating the term…
Abstract
The present invention relates to an improved process for the synthesis of bendamustine, in particular, bendamustine hydrochloride of the formula (VI) and its intermediate 1-methyl-5-[bis(2-chloroethyl)amino]-1H-benzimidazol-2-yl]lithium butanoate of formula (V), both having a purity of ≧99%, which is simple, convenient, economical, does not use hazardous chemicals and is industrially viable.
Claims11
-38. (canceled)
The lithium salt of 4-[1-methyl-5-bis-(2-chloroethyl)-benzimidazolyl-2]butyric acid of formula (V)
A process for preparing a lithium salt of 4-[1-methyl-5-bis-(2-chloroethyl)-benzimidazolyl-2]butyric acid of formula (V)
- comprising hydrolyzing the compound of formula (IV), wherein R is C1-C6 alkyl,
- with a lithium source in the presence of a solvent.
Dependencies are inferred from the claim text.